ECSP003402A - INHIBITORS OF SORBITOL DEHYDROGENASE - Google Patents

INHIBITORS OF SORBITOL DEHYDROGENASE

Info

Publication number
ECSP003402A
ECSP003402A ECSP003402A ECSP003402A EC SP003402 A ECSP003402 A EC SP003402A EC SP003402 A ECSP003402 A EC SP003402A EC SP003402 A ECSP003402 A EC SP003402A
Authority
EC
Ecuador
Prior art keywords
diabetic
relates
formula
methods
compounds
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Banavara Lakshman Mylari
W J Zembrowski
Jerry Anthony Murry
Margaret Yuhua Chu-Moyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003402 priority Critical patent/ECSP003402A/en
Publication of ECSP003402A publication Critical patent/ECSP003402A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a compuestos inhibidores de la sorbitol deshidrogenasa de la fórmula I (gráfico), em la que R1,R2,R3 son como se ha definido en la memoria descriptiva. Esta invención también se refiere a composiciones farmacéuticas que contienen estos compuestos y a procedimientos de tratamiento o prevención de las complicaciones diabéticas, las macroangiopatía diabética y la cardiomipatía diabética particularmente la neuropatía diabética, la nefropatía diabética, la macroangiopatía diabética, mediante la administración de tales compuestos a un mamifero que sufre diabetes por lo tanto, puede desarrollar tales complicaciones. Esta invención también se refiere a composiciones farmacéuticas que comprenden una combinación de un compuesto de la fórmula I de esta invención con un inhibidor de la aldosa reductasa y a procedimientos de tratamiento o prevención decomplicaciones diabéticas con tales composiciones. Esta invención también se refiere a composiciones farmacéuticas que comprenden una combionación de un compuesto de fórmula I de esta invención con un inhibidor de NHE-1 y a procedimientos de tratamiento de cardiomiopatias y otros problemas ralecionados con el corazón con tales composiciones. Esta invención también se refiere a ciertos intermedios usados en la sintesis de los compuestos de fórmula I y a procedimientos para preparar esos intermedios.The invention relates to sorbitol dehydrogenase inhibitor compounds of the formula I (graph), in which R1, R2, R3 are as defined in the specification. This invention also relates to pharmaceutical compositions containing these compounds and to methods of treatment or prevention of diabetic complications, diabetic macroangiopathy and diabetic cardiomipathy particularly diabetic neuropathy, diabetic nephropathy, diabetic macroangiopathy, by administering such compounds to A mammal who suffers from diabetes can therefore develop such complications. This invention also relates to pharmaceutical compositions comprising a combination of a compound of the formula I of this invention with an aldose reductase inhibitor and methods of treating or preventing diabetic complications with such compositions. This invention also relates to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an NHE-1 inhibitor and methods of treating cardiomyopathy and other heart-related problems with such compositions. This invention also relates to certain intermediates used in the synthesis of the compounds of formula I and to methods for preparing those intermediates.

ECSP003402 2000-03-27 2000-03-27 INHIBITORS OF SORBITOL DEHYDROGENASE ECSP003402A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003402 ECSP003402A (en) 2000-03-27 2000-03-27 INHIBITORS OF SORBITOL DEHYDROGENASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003402 ECSP003402A (en) 2000-03-27 2000-03-27 INHIBITORS OF SORBITOL DEHYDROGENASE

Publications (1)

Publication Number Publication Date
ECSP003402A true ECSP003402A (en) 2001-10-25

Family

ID=42041032

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003402 ECSP003402A (en) 2000-03-27 2000-03-27 INHIBITORS OF SORBITOL DEHYDROGENASE

Country Status (1)

Country Link
EC (1) ECSP003402A (en)

Similar Documents

Publication Publication Date Title
UY26089A1 (en) SORBITOL DEHYDROGENASE INHIBITORS
PT1041068E (en) COMPOUNDS FOR THE TREATMENT AND PREVENTION OF DIABETIC COMPLICATIONS
SV2008003045A (en) AMINOTETRAHYDROPIRANS AS DIPERTIDIL INHIBITORS, PEPTIDASE-IV FOR THE TREATMENT OR PREVENTION OF DIABETES
GT200500102A (en) ORTOSUSTITUTED ARIL-O-HETEROARILAMIDE COMPOUNDS
PA8649101A1 (en) FUNGICIDE COMPOSITIONS
ECSP066968A (en) METHYL-ARIL OR HETEROARIL-AMIDA SUBSTITUTED COMPOUNDS
GT200900183A (en) ISOQUINOLIN AND ISOQUINOLINONA DERIVATIVES REPLACED WITH CYCLLOKYLAMINE
CL2004000969A1 (en) COMPOUNDS DERIVED FROM ALQUILARILO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT AND / OR PROFILAXIS OF OBESITY AND RELATED DISORDERS.
UY27237A1 (en) ALDOSA REDUCTASA INHIBITORS OF THE PIRIDAZINONAS GROUP
PA8632701A1 (en) THERAPEUTIC COMPOUNDS
CO6382129A2 (en) AMINOTETRAHYDROPIRANS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA-IV FOR THE TREATMENT OR PROVENTION OF DIABETES
ECSP088103A (en) NEW DERIVATIVES OF 2-AZETIDINONE AS INHIBITORS OF CHOLESTEROL ABSORPTION FOR THE TREATMENT OF HYPERLIPIDEMIA CONDITIONS
BRPI0506662B8 (en) glucokinase activating compounds
ECSP088429A (en) DIARILURES FOR THE TREATMENT OF PULMONARY HYPERTENSION
UY30387A1 (en) NEW COMPOUNDS
SV2007002007A (en) SUBSTITUTED QUINOLINE COMPOUNDS REF. PC 25932A
GT200600327A (en) CYCLHEXILAMINOISOQUINOLONA
ATE368666T1 (en) PYRAZOLOPYRIMIDINONES AND THEIR USE AS PDE INHIBITORS
UY28248A1 (en) CHINICAL COMPOUNDS
CR8111A (en) PIRROL REPLACED DERIVATIVES
ECSP003402A (en) INHIBITORS OF SORBITOL DEHYDROGENASE
ECSP078015A (en) 4-ANILINO-3-QUINOLINOCARBONITRILOS FOR THE TREATMENT OF CANCER
GT200500219A (en) 4- (2,4-DICLORO-5-METOXIFENIL) AMINO-6-METOXI-7 ([5-AMINO-REPLACED) METHYL] -3-FURIL) -3-QUINOLINCARBONITRILOS AS QUINASA INHIBITORS.
PA8593701A1 (en) [4- (3-AMINOMETILPHENYL) PIPERIDIN-1-IL] - [5- (2-FLUOROPHENYL-ETINYL) FURAN-2-IL] -METANOMA AS A MASTOCYT TRIPTASE INHIBITOR
BR0316017A (en) Compounds, process for preparing them, suitable agent for combating harmful fungi, and process for combating phytopathogenic harmful fungi